Lupkynis

Generic name: Voclosporin
Drug class: Calcineurin inhibitors

Usage of Lupkynis

Lupkynis is a calcineurin-inhibitor immunosuppressant medicine.

Lupkynis is a prescription medicine used together with other medicines to treat kidney problems (active lupus nephritis) in adults with system lupus erythematous (SLE).

Lupkynis should not be taken with a medicine called cyclophosphamide. Talk with your healthcare provider if you are not sure if you take this medicine.

Lupkynis is supplied as an oval pink/orange capsule, imprinted on one side with VCS in white ink, packed in aluminum blisters.

Lupkynis side effects

Get emergency medical help if you have signs of an allergic reaction to Lupkynis: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

pain or burning when you urinate;

kidney problems - little or no urination, swelling in your feet or ankles, feeling tired or short of breath;

high blood pressure - severe headache, blurred vision, pounding in your neck or ears;

nervous system problems - confusion, vision changes, headache, feeling less alert, tremors, numbness, tingling, seizure;

high potassium level - nausea, weakness, tingly feeling, chest pain, irregular heartbeats, loss of movement; or

low red blood cells (anemia) - pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet.

Common Lupkynis side effects may include:

kidney problems;

anemia;

high blood pressure;

stomach pain, heartburn, loss of appetite, diarrhea;

tremors;

mouth sores;

headache, tiredness;

painful urination;

cough; or

hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Lupkynis

You should not use Lupkynis if you are allergic to voclosporin.

Many drugs can interact and cause dangerous effects. Some drugs should not be used together with Lupkynis. Your doctor may change your treatment plan if you also use:

cyclophosphamide;

nefazodone;

an antibiotic - clarithromycin, telithromycin;

antifungal medicine - itraconazole, ketoconazole, posaconazole, voriconazole; or

antiviral medicine to treat HIV or hepatitis C -boceprevir, cobicistat, dasabuvir, elvitegravir, indinavir, lopinavir/ritonavir, nelfinavir, ombitasvir, paritaprevir saquinavir, telaprevir, tipranavir.

When taking Lupkynis with other medicine: To make sure all medicines are safe for you, tell your doctor about all your medical conditions, and if you are pregnant or breastfeeding.

heart rhythm problems;

long QT syndrome (in you or a family member);

an electrolyte imbalance (such as low levels of potassium or magnesium in your blood);

high blood pressure; or

liver or kidney disease.

Taking Lupkynis may increase your risk of certain cancers such as skin cancer or lymphoma. Ask your doctor about your specific risk.

Tell your doctor if you are pregnant or plan to become pregnant. Voclosporin contains alcohol and should not be used during pregnancy. However, having untreated active lupus nephritis during pregnancy may cause complications such eclampsia (dangerously high blood pressure that can lead to medical problems in both mother and baby). The benefit of treating your kidney problems may outweigh any risks to the baby.

Lupkynis is sometimes used in combination with another medicine called mycophenolate mofetil. Using mycophenolate mofetil during pregnancy can cause a miscarriage or birth defects. Both men and women should use effective birth control to prevent pregnancy during and shortly after treatment with mycophenolate mofetil (women for 6 weeks after and men for 90 days after).

Do not breastfeed while using Lupkynis, and for at least 7 days after your last dose.

Relate drugs

How to use Lupkynis

Usual Adult Dose for Lupus Nephritis:

23.7 mg orally twice a day Comments: -The use of this drug in combination with cyclophosphamide is not recommended as safety and efficacy have not been established. -Use this drug in combination with mycophenolate mofetil (MMF) and corticosteroids. -Determine an actual baseline estimated glomerular filtration rate (eGFR) prior to initiating treatment. -Dosage of this drug is based on the patient's eGFR and should be modified accordingly. -Check blood pressure (BP) at baseline and do not initiate treatment in patients with BP greater than 165/105 mmHg or with hypertensive emergency. -Treatment discontinuation should be considered if the patient does not experience therapeutic benefit by 24 weeks. -Safety and efficacy have not been established beyond one year. Use: In combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis

Warnings

Taking Lupkynis may increase your risk of certain cancers such as skin cancer or lymphoma.

Voclosporin affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, sweating, cough, skin sores, muscle aches, or other flu-like symptoms.

Do not take Lupkynis with medicines known as strong CYP3A4 inhibitors such as ketoconazole, itraconazole, and clarithromycin.

Tell your doctor about all your current medicines and any you start or stop using. Many drugs can interact, and some drugs should not be used together.

What other drugs will affect Lupkynis

Voclosporin can cause a serious heart problem. Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV.

Many drugs can interact with voclosporin, and some drugs should not be used at the same time. Tell your doctor about all your current medicines and any medicine you start or stop using. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.